Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSTR vs GSK✓SelectedUSD · GSKMSTR vs GSK performance historyLatest closeAs of-6.34%11/17
Stock and ETF performance explorer

MSTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-50.6%
GSK return
+7.1%
Excess return
-57.8%
Maximum drawdown
-60.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.3%-2.3%-4.0%-6.1%
7D-20.3%-3.0%-17.3%-20.1%
30D-29.5%+0.4%-29.8%-29.5%
3M-1.2%-1.2%0.0%-1.1%
6M-45.6%+0.9%-46.5%-45.7%
YTD-36.5%+4.0%-40.5%-36.3%
1Y-50.6%+7.3%-57.9%-51.0%
All-50.6%+7.1%-57.8%-51.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling